Vous êtes ici

Home › Inscriptions › Sciences Biologiques › Onco-Innovations Limited

Onco-Innovations Limited

Onco-Innovations Limited
Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
ONCO
Indice CSE: 
Devise: 

Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.

Vous êtes ici

Accueil

Onco-Innovations Limited (ONCO)

SEDAR Information

Formulaire de recherche

Information d'entreprise

Addresse
1309-7th Street SW
Vancouver, BC V6C 2B5
Canada
Téléphone
(236) 521-0626
Courriel
nl@amalficorp.ca
URL
https://www.oncoinnovations.com
Date d’inscription à la cote
Mardi, novembre 26, 2024
Agent de transfert
Endeavor Trust Corporation

Capitalisation

Capitalisation: 
46333310
Réservé à l'émission: 
8330583

Company Officers

Thomas O'Shaughnessy, CEO
Nico Mah, CFO and Corporate Secretary

Communiqués de presse

27/02/2025

NEWS RELEASE Onco-Innovations’ Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research

24/02/2025

NEWS RELEASE - Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile

Bulletins

Dépôts CSE

FORM 10 NOTICE OF PROPOSED SIGNIFICANT TRANSACTION (Venture Liquidity Providers Inc.)

FORM 9 NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES

FORM 10 NOTICE OF PROPOSED SIGNIFICANT TRANSACTION (MCS Extension)

CONFIRMATION LETTER (PRIVATE PLACEMENT)

FORM 6 CERTIFICATE OF COMPLIANCE (PRIVATE PLACEMENT)